Immediate Impact
2 by Nobel laureates 56 standout
Citing Papers
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2023 Standout
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
2023 Standout
Works of Nimrod Maimon being referenced
Fatal pulmonary Mycobacterium xenopi in a patient with rheumatoid arthritis receiving etanercept
2007
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Nimrod Maimon | 462 | 264 | 318 | 343 | 60 | 1.2k | |
| Amit Banga | 470 | 410 | 265 | 572 | 88 | 1.4k | |
| H. Schäfer | 427 | 142 | 318 | 550 | 47 | 1.2k | |
| Vincent A. DeBari | 326 | 220 | 312 | 189 | 99 | 1.4k | |
| Sigurd Steinshamn | 595 | 145 | 255 | 395 | 70 | 1.5k | |
| Ka Pang Chan | 414 | 286 | 248 | 273 | 56 | 1.2k | |
| Jaime Signes‐Costa | 404 | 88 | 192 | 379 | 47 | 989 | |
| Marcelo Fouad Rabahi | 332 | 159 | 313 | 292 | 81 | 1.1k | |
| Yung‐Che Chen | 430 | 101 | 200 | 306 | 75 | 1.1k | |
| David Wensley | 631 | 366 | 427 | 226 | 60 | 1.6k | |
| Erkan Çakır | 434 | 202 | 260 | 218 | 96 | 1.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...